Cap displayed in your preferred currency (USD)
Industries & Sectors
| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| North America (Primary) | PRIMARYNOAM | Univ | 8,145 | 59,660,955 | 0.15% | 1.60% | 6.01% | 6.51% | 16.95% | 26.43% |
| Healthcare | HEALTHCARE | Sector | 1,333 | 6,612,544 | 0.02% | 1.84% | 6.01% | 1.11% | 14.01% | 14.79% |
| Biopharmaceuticals | BIOPHARMA | SubSec | 675 | 3,052,063 | -0.14% | 2.02% | 4.26% | -1.18% | 23.58% | 30.63% |
| System-Specific Biopharmaceuticals | BIOPHARMASYS | Industry | 308 | 1,574,549 | 0.13% | 2.15% | 4.25% | 0.24% | 22.96% | 18.88% |
| Dermatology Biopharmaceuticals | DERMATOLOGY | SubInd | 25 | 23,470 | -1.63% | 2.81% | 5.55% | 4.59% | 29.36% | 2.14% |
Show Stocks
Sort: 6Mo %
| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| Arcutis Biotherapeutics, Inc. | ARQT:USAARQT:USA | Stock | 1 | 1,063 | 0.88% | 17.35% | -2.65% | -2.95% | 371.79% | -2.65% |
| Apogee Therapeutics, Inc. | APGE:USAAPGE:USA | Stock | 1 | 2,941 | -6.40% | -5.47% | 4.05% | 45.83% | 199.29% | N/A |
| Protagonist Therapeutics, Inc. | PTGX:USAPTGX:USA | Stock | 1 | 1,801 | -3.76% | 8.89% | 21.89% | 12.89% | 90.69% | 22.76% |
| Krystal Biotech, Inc. | KRYS:USAKRYS:USA | Stock | 1 | 4,681 | 0.20% | 6.04% | 0.08% | 46.99% | 66.87% | 87.65% |
| Evolus, Inc. | EOLS:USAEOLS:USA | Stock | 1 | 846 | -0.80% | 6.59% | 17.56% | 2.10% | 50.67% | 37.41% |
| Dermatology Biopharmaceuticals | DERMATOLOGY | SubInd | 25 | 23,470 | -1.63% | 2.81% | 5.55% | 4.59% | 29.36% | 2.14% |
| Roivant Sciences Ltd. | ROIV:USAROIV:USA | Stock | 1 | 9,039 | -1.58% | 0.90% | 8.40% | -2.69% | 24.50% | 23.54% |
| S&P 500 | SPY:USASPY:USA | Benchmark | 14,703 | 77,878,209 | 0.14% | 1.65% | 5.99% | 6.91% | 18.44% | 28.12% |
| Taro Pharmaceutical Industries Ltd. | TARO:USATARO:USA | Stock | 1 | 1,590 | 0.24% | 0.00% | 0.26% | 0.09% | 18.16% | 45.96% |
* Colors indicate performance relative to the benchmark.